Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease

Thromb Res. 2017 Apr:152:4-6. doi: 10.1016/j.thromres.2017.02.003. Epub 2017 Feb 7.

¹ Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: itheb007@uottawa.ca.
² Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada.
³ Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Western Ontario, London, Ontario, Canada. Electronic address: pwells@toh.ca.

No abstract available

Publication types